SNMMI conference accolades for team members
This past week, the annual meeting of the Society of Nuclear Medicine & Molecular Imaging (SNMMI) imaging was held. Congratulations to our team members:
This past week, the annual meeting of the Society of Nuclear Medicine & Molecular Imaging (SNMMI) imaging was held. Congratulations to our team members:
19 accepted works by our team and collaborators (5 oral; 14 posters) are being presented at the 2021 Annual Meeting of the Society of Nuclear Medicine & Molecular Imaging (June 11-15):
Eleven accepted works by our team and collaborators (5 oral; 6 posters) are being presented at the 2019 Annual Congress of the European Association of Nuclear Medicine (EANM), taking place in Barcelona on October 12-16:
The published abstracts can now be found here:
https://rahmimlab.com/publications/conference_proceedings/
Eight accepted works by our group and collaborators (4 oral; 4 posters) are being presented at the 2019 Annual Meeting of the Society of Nuclear Medicine &
Thirteen accepted works by our group and collaborators (8 oral and 5 posters) are being presented at the 2018 Annual Meeting of the Society of Nuclear Medicine & Molecular Imaging (SNMMI) in Philadelphia June 23-26:
Eight works by our group and collaborators have been accepted at the 2017 annual meeting of the Society of Nuclear Medicine & Molecular Imaging (SNMMI), taking place at Denver Colorado from June 10-14. We look forward to presenting these works (5 oral presentations and 3 posters) at this always excellent meeting:
Five conference submissions related to our BRAIN initiative efforts have been accepted as oral presentations at 2017 SPIE conferences (first four at Photonics West and last one at
Eight submissions from our lab and our collaborations were accepted (5 orals, 3 posters) to the annual meeting of the Society of Nuclear Medicine & Molecular Imaging (SNMMI), held in San Diego this year (June 11-15, 2016). This is always a fantastic meeting that brings together the best in the field, with very strong basic science and clinical tracks. The abstracts are as follows:
Our conference paper to the OSA Biomedical Optics Conference (BIOMED) has been accepted for presentat
BC Cancer Foundation is the fundraising partner of BC Cancer, which includes BC Cancer Research. Together with our donors, we are changing cancer outcomes for British Columbians by funding innovative research and personalized treatment and care.